The ACME Laboratories Ltd. (DSE:ACMELAB)

The ACME Laboratories Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1,451	1,752	1,455	1,239	1,594	1,824
Short-Term Investments	1,185	56.32	50.45	48.14	180.12	278.07
Cash & Short-Term Investments	2,636	1,808	1,506	1,287	1,774	2,102
Cash Growth	-3.57%	20.09%	17.00%	-27.45%	-15.60%	10.51%
Accounts Receivable	3,506	3,259	2,705	2,236	2,216	1,911
Other Receivables	84.63	20.13	19.89	19.81	19.93	19.73
Receivables	3,591	3,279	2,725	2,256	2,236	1,931
Inventory	13,081	11,871	10,234	7,879	5,124	5,231
Prepaid Expenses	35.02	17.36	15.61	14.01	13.09	12.06
Other Current Assets	6,586	6,886	6,655	5,907	6,193	5,430
Total Current Assets	25,928	23,863	21,136	17,343	15,341	14,706
Property, Plant & Equipment	32,604	31,729	29,243	25,599	25,100	24,689
Long-Term Investments	32.1	30.2	31.52	32.88	35.51	23.77
Other Intangible Assets	-	-	-	0	0.02	0.04
Total Assets	58,564	55,622	50,410	42,975	40,476	39,418
Accounts Payable	465.3	603.67	490.89	449	350.25	398.97
Accrued Expenses	740.03	600.01	553.26	574.63	508.59	419.86
Short-Term Debt	16,832	15,053	12,523	9,383	7,141	8,315
Current Portion of Long-Term Debt	2,156	2,115	2,054	2,328	2,601	2,459
Current Portion of Leases	25.88	21.49	21.86	22.33	14.27	11.64
Current Income Taxes Payable	3,811	3,022	3,255	2,661	2,856	2,367
Current Unearned Revenue	-	111.83	48.2	14.46	8.33	3.19
Other Current Liabilities	3.88	3.83	6.51	4.38	7.23	6.74
Total Current Liabilities	24,034	21,531	18,953	15,438	13,487	13,982
Long-Term Debt	6,050	6,753	6,168	4,175	5,442	5,107
Long-Term Leases	74.45	44.87	62.29	73.2	62.88	66.78
Long-Term Deferred Tax Liabilities	728.64	790.57	903.14	907.59	873.54	857.26
Total Liabilities	32,498	30,570	27,115	21,285	20,366	20,374
Common Stock	2,116	2,116	2,116	2,116	2,116	2,116
Additional Paid-In Capital	5,128	5,128	5,128	5,128	5,128	5,128
Retained Earnings	13,879	12,833	11,029	9,304	7,675	6,564
Comprehensive Income & Other	4,943	4,975	5,022	5,142	5,192	5,237
Shareholders' Equity	26,066	25,052	23,295	21,690	20,111	19,044
Total Liabilities & Equity	58,564	55,622	50,410	42,975	40,476	39,418
Total Debt	25,139	23,988	20,829	15,982	15,262	15,960
Net Cash (Debt)	-22,503	-22,179	-19,324	-14,694	-13,488	-13,858
Net Cash Per Share	-106.35	-104.82	-91.32	-69.44	-63.74	-65.49
Filing Date Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Total Common Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Working Capital	1,894	2,332	2,182	1,905	1,853	723.73
Book Value Per Share	123.18	118.39	110.09	102.50	95.04	90.00
Tangible Book Value	26,066	25,052	23,295	21,690	20,111	19,044
Tangible Book Value Per Share	123.18	118.39	110.09	102.50	95.04	90.00
Land	-	5,419	5,233	5,228	4,967	4,954
Buildings	-	12,236	9,649	8,112	6,770	6,618
Machinery	-	17,346	16,538	13,018	12,934	11,967
Construction In Progress	-	3,756	4,367	4,820	5,442	4,912

Updated Feb 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.